Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
- Substances:AnastrozoleCamizestrant+6
Hungary- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Hungary1 052 clinical trials in Budapest, Hungary across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
HungaryStudy on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery
HungaryStudy on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide
HungaryStudy on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer
HungaryStudy on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia
HungaryStudy on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17
HungaryLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
HungaryStudy on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine
HungaryStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
HungaryEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
HungaryStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
HungaryPhase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for inflammatory disorders, including studies on new therapies for psoriasis, psoriatic arthritis, and chronic urticaria.
Multiple clinical trials are investigating targeted therapies and their long-term effectiveness in managing inflammatory conditions.
Studies centered on preventing and treating various infections, with particular emphasis on meningococcal vaccines and respiratory conditions.
Research includes both preventive vaccines and therapeutic approaches for various infectious diseases.
Comprehensive research into heart failure prevention and management of chronic conditions, including studies on kidney disease and obesity.
Investigations focus on innovative therapeutic combinations and their impact on cardiovascular outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.